We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Metabolomic in Critical Ill Patients

This study is currently recruiting participants.
Verified March 2017 by Giovanni Landoni, Università Vita-Salute San Raffaele
Sponsor:
ClinicalTrials.gov Identifier:
NCT01506674
First Posted: January 10, 2012
Last Update Posted: March 9, 2017
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
Information provided by (Responsible Party):
Giovanni Landoni, Università Vita-Salute San Raffaele
January 9, 2012
January 10, 2012
March 9, 2017
January 2015
December 2017   (Final data collection date for primary outcome measure)
Metabolomic patterns to identify poor outcome [ Time Frame: hospital stay (approximately two weeks) ]
Not Provided
Complete list of historical versions of study NCT01506674 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Metabolomic in Critical Ill Patients
Not Provided
Analysis of blood, urinary, and intrathecal metabolites of critical ill patients will be checked for possible correlations between metabolomics patterns and patients' outcomes.
Not Provided
Observational
Observational Model: Cohort
Time Perspective: Prospective
Not Provided
Not Provided
Non-Probability Sample
Critical ill patients
Metabolomic
Not Provided
criticall ill patients
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruiting
Not Provided
December 2017
December 2017   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • patients with severe left or right ventricular dysfunction undergoing cardiac surgery
  • patients undergoing ablation of ventricular tachycardia
  • patients with febrile neutropenia after chemotherapy or allogeneic transplant for haematological diseases
  • patients undergoing thoracoabdominal vascular surgery

Exclusion Criteria:

  • pregnant women
  • no written consent
Sexes Eligible for Study: All
18 Years to 99 Years   (Adult, Senior)
No
Italy
 
 
NCT01506674
HSR CEmet
Not Provided
Not Provided
Not Provided
Giovanni Landoni, Università Vita-Salute San Raffaele
Università Vita-Salute San Raffaele
Not Provided
Not Provided
Università Vita-Salute San Raffaele
March 2017